just having a brief look at TCM.if they get ticks in the right boxes in coming months / years they could have a very bright future.Chinese backers also adds plenty of appeal.i think you might be on a winner here.2 YEAR MONTHLY CHART.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%